This is a working overview of Nuclear receptor, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-11-11 and is reviewed periodically as new material appears.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
| Property | Value | Notes |
|---|---|---|
| Chemical class | PPARδ agonist | Not an anabolic steroid. |
| Common synonyms | GW501516, GW-1516 | Cardarine is an informal name. |
| Appearance | White to off-white powder | Typical for research-grade solid. |
| Solubility class | Poorly soluble in water; soluble in some organic solvents | Such as DMSO or ethanol in laboratory settings. |
| Typical storage temperature | Cool, dry, protected from light | Specific conditions vary by supplier and form. |
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Diacetyl production is favored in fermentations that run warm with temperatures between 18 and 25 °C (64 and 77 °F). It also tends to be produced at higher levels in wines with lower pH levels (under 3.5), though at levels below 3.2, most strains of LAB desirable for MLF tend to be inhibited. "Wild" (as in uninoculated) malolactic ferments have the potential to produce more diacetyl than inoculated ferments due to the lower initial populations during the lag phase with inoculated ferments usually having an initial inoculum of 106 CFU/mL. Late MLF inoculations, after alcoholic fermentation, also tend to produce higher levels of diacetyl. Chardonnay producers desiring to make the high-diacetyl "buttery style" will often do late or "wild" inoculation in the barrel after primary fermentation, allowing the wine to spend several weeks or even months sur lie in reductive conditions that promote diacetyl production. Some sources point out that diacetyl is actually decreased by sur lie, due to surviving yeast metabolizing diacetyl, and therefore malolactic fermentation is best performed apart from lees. With wines that have excessive levels of diacetyl, some winemakers use sulfur dioxide to bind with the compound and reduce the perception of diacetyl by 30 to 60%. This binding is a reversible process and after only a few weeks aging in the bottle or tank, the high levels of diacetyl return.
CK1δ is involved in different developmental pathways, among them Wingless (Wnt)-, Hedgehog (Hh)-, and Hippo (Hpo)-pathways. In the Wnt pathway, CK1δ can phosphorylate different factors of the pathway, among them Dishevelled (Dvl), Axin, APC, and β-catenin. CK1δ also negatively influences the stability of β-catenin, after its phosphorylation on Ser-45, which permits GSK3β-mediated further phosphorylations and subsequent degradation.
=== 2022: In the Court of the Crimson King documentary; end of band activity === Following the band's 2021 tour dates, King Crimson ceased activity without expressly announcing a breakup. Fripp cited practical reasons for concluding the band's touring career, such as the old age of several of the members and the rising cost of services during the COVID-19 pandemic. On 9 February 2022, founding King Crimson member Ian McDonald died of cancer. In March 2022, the documentary film In the Court of the Crimson King was premiered at the 2022 SXSW Film Festival. Directed by Toby Amies and filmed between 2019 and 2021, it covered live and backstage activity by the then-current band but also featured a historical overview plus contributions from Crimson alumni Ian McDonald, Michael Giles, Bill Bruford, Adrian Belew and Trey Gunn (as well as prolonged interview footage with the late Bill Rieflin). Amies described the film's development as follows: "What began as a traditional documentary about the legendary band King Crimson as it turned fifty, mutated into an exploration of time, death, family, and the transcendent power of music to change lives; but with jokes." As of 2022, no King Crimson activity was planned for the future, excepting ongoing archive/curatorial matters. Levin said in a late 2022 interview that "the sense I got from Robert [Fripp] was that it's over.
Sources: en.wikipedia.org
== Further reading == Immunologists' Toolbox: Immunization. In: Charles Janeway, Paul Travers, Mark Walport, Mark Shlomchik: Immunobiology. The Immune System in Health and Disease. 6th Edition. Garland Science, New York 2004, ISBN 0-8153-4101-6, p. 683–684 Descotes, Jacques (March 2009). "Immunotoxicity of monoclonal antibodies". mAbs. 1 (2): 104–111. doi:10.4161/mabs.1.2.7909. PMC 2725414. PMID 20061816. The European Immunogenicity Platform http://www.e-i-p.eu Archived 2023-12-06 at the Wayback Machine De Groot, Anne S.; Martin, William (May 2009). "Reducing risk, improving outcomes: Bioengineering less immunogenic protein therapeutics". Clinical Immunology. 131 (2): 189–201. doi:10.1016/j.clim.2009.01.009. PMID 19269256. Porcelli, Steven A.; Modlin, Robert L. (April 1999). "THE CD1 SYSTEM: Antigen-Presenting Molecules for T Cell Recognition of Lipids and Glycolipids". Annual Review of Immunology. 17 (1): 297–329. doi:10.1146/annurev.immunol.17.1.297. PMID 10358761. Cruse, Julius M.; Lewis, Robert E. (1998). Atlas of Immunology. Boca Raton: CRC Press. ISBN 978-0-8493-9489-8.
Turin (Italian: Torino) is a city and a business and cultural centre in northern Italy. It is the capital and largest city of Piedmont and of the Metropolitan City of Turin. From 1861 to 1865, it was the first capital of the Kingdom of Italy. The city is mainly on the western bank of the River Po, below its Susa Valley, and is surrounded by the western Alpine arch and Superga hill. The population of the city proper is 855,654 as of 2026, while the population of the urban area is estimated by Eurostat to be 1.7 million inhabitants. The Turin metropolitan area is estimated by the OECD to have a population of 2.2 million. The city was historically a major European political centre. From 1563, it was the capital of the Duchy of Savoy, then of the Kingdom of Sardinia ruled by the House of Savoy, and then the first capital of the Kingdom of Italy from 1861 to 1865. Turin is sometimes called "the cradle of Italian liberty" for having been the political and intellectual centre of the Risorgimento that led to the unification of Italy, as well as the birthplace of notable individuals who contributed to it, such as Camillo Benso, Count of Cavour. Although much of its political influence had been lost by World War II, it had become a centre of anti-fascist movements during the Ventennio fascista, including the Italian resistance movement. Postwar Turin became a major European crossroads for industry, commerce and trade, and is part of the industrial triangle, along with Milan and Genoa. In 2004 it ranked third in Italy, after Milan and Rome, for economic strength.
=== 5 December === Explosions were reported at two Russian airbases: the one at Engels-2 reportedly damaged two Tu-95s; the other at the Dyagilevo military airbase near Ryazan, destroyed a fuel truck and killed three, injuring five. The Russian Ministry of Defence stated Ukraine attempted to strike Russia's long-range aviation bombers with Soviet-made jet drones, and that the drones were subsequently shot down at low altitude when approaching the air bases. The attack involved the use of Tu-141 drones that were taken out of storage and appeared to have been fitted with improvised explosives. While no significant damage or burn marks were visible on satellite images of Engels-2, at least one Tu-22M3 bomber was visually confirmed to be slightly damaged at Dyagilevo. Following the attacks, Russia launched a renewed wave of missile strikes against Ukraine, consisting of about 70 cruise missiles. Ukraine claimed 60 missiles were shot down, Russia claimed 17 targets were hit on the ground. As a result, a missile fell into the territory of Moldova, near the city of Briceni.
Sources: en.wikipedia.org
=== Electron capture === The analogous calculation for electron capture must take into account the binding energy of the electrons. This is because the atom will be left in an excited state after capturing the electron, and the binding energy of the captured innermost electron is significant. Using the generic equation for electron capture
=== Enzymes === Enzymes are involved in internal processes within mast cells including signaling pathways for mast cell activation and other mechanisms regulating cellular functions. They can include:
== Ecological importance == Anaerobic respiration is a critical component of the global nitrogen, iron, sulfur, and carbon cycles through the reduction of the oxyanions of nitrogen, sulfur, and carbon to more-reduced compounds. The biogeochemical cycling of these compounds, which depends upon anaerobic respiration, significantly impacts the carbon cycle and global warming. Anaerobic respiration occurs in many environments, including freshwater and marine sediments, soil, subsurface aquifers, deep subsurface environments, and biofilms. Even environments that contain oxygen, such as soil, have micro-environments that lack oxygen due to the slow diffusion characteristics of oxygen gas. An example of the ecological importance of anaerobic respiration is the use of nitrate as a terminal electron acceptor, or dissimilatory denitrification, which is the main route by which fixed nitrogen is returned to the atmosphere as molecular nitrogen gas. The denitrification process is also very important in host-microbe interactions. Like mitochondria in oxygen-respiring microorganisms, some single-cellular anaerobic ciliates use denitrifying endosymbionts to gain energy. Another example is methanogenesis, a form of carbon-dioxide respiration, that is used to produce methane gas by anaerobic digestion. Biogenic methane can be a sustainable alternative to fossil fuels. However, uncontrolled methanogenesis in landfill sites releases large amounts of methane into the atmosphere, acting as a potent greenhouse gas.
Garden officials called the plans "pie-in-the-sky", but on July 24, 2013, the New York City Council voted 47–1 to give the Garden a ten-year operating permit, after which the owners would have to move or seek permission anew. In January 2016, at the same time he announced the development of Moynihan Train Hall, New York governor Andrew Cuomo announced he would solicit proposals for the redevelopment of the station under the Garden as a public-private partnership called the Empire Station Complex. In June 2023, nearing the end of the ten-year permit granted in 2013, the MTA, Amtrak, and NJ Transit filed a report stating Madison Square Garden was no longer compatible with Penn Station, saying, "MSG's existing configuration and property boundaries impose severe constraints." On September 14, 2023, the New York City Council voted 48–0 to renew the operating permit for Madison Square Garden for five years, the shortest-ever granted to the Garden by the city.
Sources: en.wikipedia.org
Cardarine is commonly known as GW501516 or GW-1516. These names refer to the same synthetic compound. It is not a brand-name approved medicine.
No, cardarine is not a steroid. It is classified as a PPARδ agonist. Its structure and receptor target differ from anabolic steroids.
No regulatory agency has approved cardarine as a medicine. It was investigated in early research but development was discontinued. It is not available as a prescription drug.
No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.